Real-world effectiveness of COVID-19 vaccines and anti-SARS-CoV-2 monoclonal antibodies against postacute sequelae of SARS-CoV-2: analysis of a COVID-19 observational registry for a diverse US metropolitan population.
Jonika TannousAlan P PanThomas PotterAbdulaziz T BakoKatharine DlouhyAshley DrewsHenry Dirk SostmanFarhaan S VahidyPublished in: BMJ open (2023)
Although both COVID-19 vaccines and mAbs decreased the likelihood of PASC, vaccination remains the most effective tool for the prevention of long-term consequences of COVID-19.